|
Gregory Pusey became a director in 2002 and has served as the chairman of the board of directors since October 2004. He became our secretary in March 2006. Mr. Pusey is also the president, a principal shareholder and a director of Cambridge Holdings, Ltd., a publicly-held real estate and business development firm, chairman of the board of directors and director of AspenBio Pharma, Inc., a publicly-held biomedical company, and president of Livingston Capital, Ltd., a private venture capital firm. He serves as a director of Bactolac Pharmaceuticals, Inc. (formerly known as Advanced Nutraceuticals, Inc.), a privately-held company engaged in manufacturing and marketing of vitamin and nutraceutical products. Mr. Pusey has been associated with Bactolac Pharmaceuticals and its predecessors since 1997. He holds a B.S. degree in finance from Boston College. | 